Contact

Investments in Start-Ups in the month of March


, ,
Integral service around a transaction
BY : Diego GutiérrezApril Tue, 2020

Despite the coronavirus crisis, March has been a good month for investments in Spanish Start-ups, as the month closed with a total amount invested in Start-ups, similar to that of March last year (11.7 million euros in March 2020 compared to 11.3 million in March 2019).

A total of 19 public operations have taken place, all of them in the early stages and under €1.5 million per transaction. In addition, seven of them have taken place through the main equity crowdfunding platforms in Spain.

However, in this post we are going to analyse two of the start-ups that have raised funds this March, both of which are dedicated to the development of medical technologies. These two companies are Aortyx y Qrem.

Start-ups: AORTYX

Aortyx is an IQS spin-off company that develops an endovaortyx start-upsThe company has launched a new minimally invasive aortic dissection device to reduce the mortality rate in aortic dissections. The company has kicked off 2020 with the closing of an investment round. seed amounting to 650,000 euros. The transaction has been led by Genesis Ventures, which has invested along with the other 71 investors that Aortyx currently has.

With the funding raised, the company has already started animal testing and will begin industrialisation of its product with the aim of commercialisation in 2024. Dr Jordi Martorell, CEO and co-founder of Aortyx, said: "This investment will allow us to continue to meet our timeline and maintain our goal of bringing the best possible product to market.

Start-ups: QREM

Qrembased in Barcelona, specialises in the development and commercialisation of Lab-in-a-Box medical technologies to carry out autologous regenerative medicine treatments with the patient in the doctor's office, making it possible to offer these therapies to as many people as possible in an effective, simple and economical way.

The start-up has committed a capital increase 1 million led by Inveready and shared with several business angels. Qrem launched its first product, Q-Cytokine, in 2019 and the funding received will allow it to strengthen the clinical validation of the therapy, as well as increase the commercial team to scale sales. As indicated by Josep M. Escuer, CEO of Qrem, "the investment allows us to close a startup stage to start a completely new commercial company that aims to reach its break-even point in the shortest possible time".

 ▶You may be interested in: The 10 Mobility Startups to watch.

Our diferentiation

Market Research Technology
Our team of market analysis specialists is continuously analyzing the investments of the most active markets in the industry in order to unceasingly contribute ideas of the current market situation and identify the most relevant trends for senior management. We integrate the most relevant sources of information which allows us to discover the most interesting companies for venture capital and similarly helps us to identify the investors with the highest probability of involvement in an M&A process to ensure the success of our sell-side operations.

The reports and deductions of our advisors provide a broad view of the sector, both geographically and from the complementary or adjacent markets perspective.
Technology Data Analytics
for M&A
Advanced data anlytics is a weapon". Intelfin is an artificial intelligence tool we use for investing and creating value in SMEs through competitive analytics and the enterprise environment.

IntelFin consists of a cognitive system, which, through the application of advanced analytical technologies, facilitates the automation of investment and financing decisions in the field of non-listed companies and especially SMEs in high-growth sectors.

The information related to these companies is characterized by their lack of transparency and heterogeneity; thus, it is necessary to develop an advanced analysis which is as much predictive as prescriptive and is developed in a natural language custom, suitable to obtain greater clarity and knowledge of the investment scope.

The IntelFin system focuses especially on analyzing the variables that define and influence the competitive environment of a sector and the positioning of a company, analyzing their influence on future value creation. Therefore, IntelFin supports strategic decision-making to senior management by resolving questions such as:

¿What are my competitors' priorities, strategies and expansion plans? Who's my competition? Which competitor is most likely to grow at a higher rate?
Which areas of activity/business models will receive the most investment? Which sectors are most attractive to investors?
Which companies are going to experience the most growth in the near future? Which companies are most likely to receive investment or be acquired?
Training Methodology
We have developed training programs in an innovative set-up which guarantees our teams the acquisition of technical competences both in the field of corporate finance and in the field of psychology, that is much needed when it comes to negotiation processes.

We have a culture of continuous improvement of our processes, closely related to the use of information systems that allow the enhancement of internal communication between our teams, as well as external communication with our customers. Hence, we extend best practices identified internally in an efficient and rapid manner among our members.

Are you one of those who prefer to be well informed when making decisions?

M&A NEWS
INDUSTRIAL REPORTS
closearrow-circle-o-downchevron-downcrossmenu